Navigation thread
Hepatocellular signaling and cancer
Featured publications
-
Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH
Grondal, SM; Lorens, JB; Tutusaus, A; de Frutos, PG; Morales, A;(...)Reig, M; Blo, M; Hodneland, L; Gausdal, G; Jackson, A.Reference:Frontiers In Immunology 2024.
-
Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular Carcinoma
Tutusaus, A; Rider, P; Subías, S; de Frutos, PG; Colell, A;Marí, M; Morales, A; Sanduzzi-Zamparelli, M; Boix, L; Reig, M.Reference:Cancers 2024.
-
Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice
Cuno-Gomiz, Carlos; de Gregorio, Estefania; Tutusaus, Anna; Rider, Patricia; Andres-Sanchez, Nuria;Colell, Anna; Morales, Albert; Mari, Montserrat.Reference:Biology Of Sex Differences 2023.
-
Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances
Cucarull, B; Tutusaus, A; Rider, P; Cuño, C; de Frutos, PG;Colell, A; Marí, M; Morales, A; Hernáez-Alsina, T.Reference:Cancers 2022.
-
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis
Martínez-Bosch, N; Barranco, L; Manero-Rupérez, N; Moreno, M; Navarro, P;(...)Visa, L; Jiménez-Parrado, S; Guerra, C; Earl, J; Carrato, A.Reference:Ebiomedicine 2022.
-
Antioxidants Threaten Multikinase Inhibitor Efficacy against Liver Cancer by Blocking Mitochondrial Reactive Oxygen Species
Cucarull, B; Tutusaus, A; de Frutos, PG; Colell, A; Marí, M;Morales, A; Hernáez-Alsina, T; Reig, M.Reference:Antioxidants 2021.
-
Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome
Morales, A; Cristóbal, H; Marí, M; Tutusaus, A; de Frutos, PG;(...)Arribas, E; de la Cal-Sabater, P; Bernardo, D; Nicolaes, GAF; Ortiz-Pérez, JT.Reference:Biomedicines 2021.
-
Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense
Bosch, Marta; Sanchez-Alvarez, Miguel; Fajardo, Alba; Kapetanovic, Ronan; Steiner, Bernhard;(...)Gross, Steven P; Gross, Steven P; Parton, Robert G; Parton, Robert G; Pol, Albert.Reference:Science 2020.
-
Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease
de Gregorio, E; Marí, M; Cole, A; Morales, A;Reference:International Journal Of Molecular Sciences 2020.
-
Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models
Cucarull, B; Tutusaus, A; Subías, M; Stefanovic, M; de Frutos, PG;(...)Morales, A; Hernáez-Alsina, T; Boix, L; Reig, M; Bruix, J.Reference:Cancers 2020.